Table 1. Patient Characteristics (N = 63).
| Demographic | |
|---|---|
| Age, years | 73.3 ± 7.6 |
| Male/female | 48 (76%)/15 (24%) |
| Height, m | 1.61 ± 0.09 |
| Weight, kg | 61.3 ± 13.2 |
| BMI, kg/m2 | 23.6 ± 4.4 |
| Medical history | |
| HT | 52 (83%) |
| DM (type 2) | 39 (62%) |
| DL | 41 (65%) |
| IHD | 32 (51%) |
| HD | 17 (27%) |
| AF | 7 (11%) |
| Current/past smoking | 40 (63%)/6 (10%) |
| Laboratory characteristics | |
| TC, mg/dL | 180 ± 38 |
| HDL-C, mg/dL | 52 ± 15 |
| LDL-C, mg/dL | 103 ± 31 |
| TG, mg/dL | 150 ± 68 |
| HbA1c, % | 6.5 ± 0.9 |
| BG, mg/dL | 135 ± 42 |
| CRP, mg/dL | 0.57 ± 1.37 |
| Clinical presentation | |
| Fontaine stage: 2/3/4 | 45 (71%)/3 (5%)/15 (24%) |
| Rutherford category: 2/3/4/5/6 | 35 (56%)/10 (16%)/3 (5%)/11 (17%)/4 (6%) |
| ABI | 0.66 ± 0.12 |
| %MAP, % | 49.9 ± 4.7 |
| UT, ms | 224 ± 51 |
Data are expressed as the mean ± SD or number (%). BMI: body mass index; HT: hypertension; DM: diabetes mellitus; DL: dyslipidemia; IHD: ischemic heart disease; HD: hemodialysis; AF: atrial fibrillation; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; HbA1c: glycated hemoglobin; BG: blood glucose; CRP: C-reactive protein; ABI: ankle-brachial index; %MAP: percentage of mean arterial pressure; UT: upstroke time.